feed,title,long_url,short_url
MedRxiv,Covaxin (BBV152) Vaccine Neutralizes SARS-CoV-2 Delta and Omicron variants,https://medrxiv.org/cgi/content/short/2022.01.24.22269189v1?rss=1,https://bit.ly/35rKHeN
MedRxiv,Is mandatory vaccination in population over 60 adequate to control the COVID-19 pandemic in E.U.?,https://medrxiv.org/cgi/content/short/2022.01.25.22269867v1?rss=1,https://bit.ly/3r67Mw6
MedRxiv,A longitudinal seroconversion panel shows anti-SARS-CoV-2 antibody levels up to 6.5 months after vaccination with mRNA-1273 (Moderna),https://medrxiv.org/cgi/content/short/2022.01.25.22269762v1?rss=1,https://bit.ly/3uf6u41
MedRxiv,"SARS-CoV-2 seroprevalence in children, parents and school personnel from June 2020 to April 2021: cohort study of 55 schools in Switzerland",https://medrxiv.org/cgi/content/short/2022.01.25.22269827v1?rss=1,https://bit.ly/3r9OkOV
MedRxiv,Positive attribute framing increases COVID-19 booster vaccine intention for unfamiliar vaccines,https://medrxiv.org/cgi/content/short/2022.01.25.22269855v1?rss=1,https://bit.ly/3r9z8kY
